NRx Pharmaceuticals (NRXP) SEC Filings & 10K Form

$2.10
+0.04 (+1.94%)
(As of 05/3/2024 ET)

Recent NRx Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/30/2024
4:26 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:46 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 10-K/A
04/19/2024
4:10 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2024
9:08 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
04/18/2024
7:21 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
04/15/2024
4:22 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2024
4:13 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B3
04/15/2024
5:00 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B3
04/02/2024
5:01 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2024
4:18 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/21/2024
4:09 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2024
4:08 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form DEFA14A
03/11/2024
4:16 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form DEF 14A
02/28/2024
4:09 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2024
9:40 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
02/26/2024
4:15 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
02/14/2024
5:03 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2024
3:37 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
3:16 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2024
5:36 PM
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Rehnquist Janet (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/29/2023
3:30 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form PRE 14A
12/29/2023
3:15 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2023
3:30 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K/A
11/22/2023
3:31 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form DEF 14A
11/22/2023
3:32 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form ARS
11/21/2023
4:23 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2023
3:05 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2023
3:04 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
8:19 AM
Gorovitz Aaron (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2023
8:15 AM
Hurvitz Chaim (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:48 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2023
4:18 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B3
08/31/2023
4:20 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/24/2023
11:14 AM
Javitt Jonathan C (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2023
8:24 AM
Javitt Jonathan C (Reporting)
NRx Pharmaceuticals (Issuer)
NRX Pharmaceuticals, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2023
4:10 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/28/2023
4:15 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/08/2023
9:21 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 424B5
06/07/2023
4:18 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K/A
06/06/2023
3:27 PM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/05/2023
7:00 AM
NRx Pharmaceuticals (Filer)
NRX Pharmaceuticals, Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
The A.I. story nobody is telling you (Read ASAP) (Ad)

There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...

Click here to see Louis' new video for yourself.
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:NRXP) was last updated on 5/4/2024 by MarketBeat.com Staff

From Our Partners